← Leaderboards
David E Briles
University Of Alabama At Birmingham
$11,417,266
Attributed
$12,415,336
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $860.3K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$12,415,336 · 6
By mechanism
R01$9,317,662 · 3
T32$1,563,200 · 1
T35$991,765 · 1
R56$542,709 · 1
Top collaborators
- Patricia Ferrieri5 shared
- Steven Sung Kyun Juhn5 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- William J Britt$28,989,956
- Etty N. Benveniste$18,164,533
- Alan Kim Johnson$11,768,946
- Benjamin H Chi$27,017,926
- Vytas A Bankaitis$16,946,786
Others in their field
Top investigators on “Streptococcus Pneumoniae”
- Jeffrey N. Weiser · New York University School Of Medicine$20,590,649
- Dallas Hughes · Novobiotic Pharmaceuticals, Llc$15,114,161
- Elaine Tuomanen · University Of Alabama At Birmingham$13,568,473
- Liise-Anne Pirofski · Yeshiva University$13,441,639
- Joseph P Mizgerd · Boston University Medical Campus$12,549,527
- Myron Max Levine · University Of Maryland Baltimore$12,500,000
Research focus
Streptococcus PneumoniaeVirulencePolysaccharidesVaccinesAntigensProteinsAntibodiesPneumococcal VaccineInfectionPreventEpitopesPathogenesisComplementImmunitySepsisSurfaceIn VitroMediatingPneumococcal InfectionsImmunizationDepositionBloodEfficacy TrialMembrane Proteins
Grant awards (40)
Vaccine potential of the proline-rich domain of pneumococcal surface protein A$367,500
R01 · FY2019 · AI · contact PI
Vaccine potential of the proline-rich domain of pneumococcal surface protein A$367,500
R01 · FY2018 · AI · contact PI
Vaccine potential of the proline-rich domain of pneumococcal surface protein A$367,500
R01 · FY2017 · AI · contact PI
Vaccine potential of the proline-rich domain of pneumococcal surface protein A$367,500
R01 · FY2016 · AI · contact PI
Vaccine potential of the proline-rich domain of pneumococcal surface protein A$367,500
R01 · FY2015 · AI · contact PI
PspA mechanisms of humoral immunity, functional assays, and optimal vaccine const$542,709
R56 · FY2014 · AI · contact PI
Effect of the Middle Ear Inflammation on the Inner Ear$295,838
R01 · FY2014 · DC
Effect of the Middle Ear Inflammation on the Inner Ear$281,432
R01 · FY2013 · DC
PspA: A Potential Pneumococcal Vaccine Component$520,733
R01 · FY2012 · AI · contact PI
Effect of the Middle Ear Inflammation on the Inner Ear$296,270
R01 · FY2012 · DC
PspA: A Potential Pneumococcal Vaccine Component$520,943
R01 · FY2011 · AI · contact PI
Effect of the Middle Ear Inflammation on the Inner Ear$296,034
R01 · FY2011 · DC
PspA: A Potential Pneumococcal Vaccine Component$529,162
R01 · FY2010 · AI · contact PI
Effect of the Middle Ear Inflammation on the Inner Ear$327,531
R01 · FY2010 · DC
PspA: A Potential Pneumococcal Vaccine Component$521,935
R01 · FY2009 · AI · contact PI
PspA: A Potential Pneumococcal Vaccine Component$52,396
R01 · FY2009 · AI · contact PI
PspA: A Potential Pneumococcal Vaccine Component$506,758
R01 · FY2008 · AI · contact PI
Molecular and Cellular Bacterial Pathogenesis$238,383
T32 · FY2008 · AI · contact PI
Mechanism of Action of Antibody to PspA$438,499
R01 · FY2007 · AI · contact PI
Molecular and Cellular Bacterial Pathogenesis$154,041
T32 · FY2007 · AI · contact PI
Mechanism of Action of Antibody to PspA$438,441
R01 · FY2006 · AI · contact PI
Molecular and Cellular Bacterial Pathogenesis$237,962
T32 · FY2006 · AI · contact PI
Mechanism of Action of Antibody to PspA$435,914
R01 · FY2005 · AI
Molecular and Cellular Bacterial Pathogenesis$242,815
T32 · FY2005 · AI
SHORT-TERM TRAINING IN HEALTH PROFESSIONAL SCHOOLS$181,529
T35 · FY2005 · HL
Mechanism of Action of Antibody to PspA$423,217
R01 · FY2004 · AI
Molecular and Cellular Bacterial Pathogenesis$235,946
T32 · FY2004 · AI
SHORT-TERM TRAINING IN HEALTH PROFESSIONAL SCHOOLS$186,073
T35 · FY2004 · HL
Mechanism of Action of Antibody to PspA$410,891
R01 · FY2003 · AI
SHORT-TERM TRAINING IN HEALTH PROFESSIONAL SCHOOLS$179,561
T35 · FY2003 · HL
IMMUNITY TO PNEUMOCOCCAL SURFACE PROTEIN A AND C$391,530
R01 · FY2002 · AI
SHORT-TERM TRAINING IN HEALTH PROFESSIONAL SCHOOLS$164,884
T35 · FY2002 · HL
MOLECULAR AND CELLULAR BACTERIAL PATHOGENESIS$164,422
T32 · FY2002 · AI
IMMUNITY TO PNEUMOCOCCAL SURFACE PROTEIN A AND C$382,729
R01 · FY2001 · AI
SHORT-TERM TRAINING IN HEALTH PROFESSIONAL SCHOOLS$149,850
T35 · FY2001 · HL
MOLECULAR AND CELLULAR BACTERIAL PATHOGENESIS$146,589
T32 · FY2001 · AI
IMMUNITY TO PNEUMOCOCCAL SURFACE PROTEIN A AND C$372,671
R01 · FY2000 · AI
MOLECULAR AND CELLULAR BACTERIAL PATHOGENESIS$143,042
T32 · FY2000 · AI
SHORT-TERM TRAINING STUDENTS IN HEALTH PROFESSIONAL SCHO$129,868
T35 · FY2000 · HL
IMMUNITY TO PNEUMOCOCCAL SURFACE PROTEIN A AND C$37,238
R01 · FY2000 · AI